Tag Archives: annual-meeting
Jan. 10, 2013 New research suggests that testing a portion of a person’s saliva gland may be a way to diagnose Parkinson’s disease.
Dec. 10, 2012 A survey highlighting the correlation between today’s cutting edge medical research and the National Institutes of Health (NIH) funding was released December 10 at the 54th Annual Meeting of the American Society of Hematology (ASH), the preeminent medical meeting for physicians and scientists in hematology that draws more than 20,000 attendees from around the world. The survey, representing responses from 1,040 abstract presenters from the U.S
Reduced intensity regimen prior to marrow transplant better for older leukemia patients, study suggests
Dec. 9, 2012 A new study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J
ScienceDaily (Sep. 22, 2012) New mouse models can help scientists study a rare disease, called SECISBP2 syndrome, that causes abnormal thyroid hormone metabolism, delayed bone maturation, as well as other abnormal characteristics that vary by individual, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada.
ScienceDaily (Sep. 22, 2012) Next-generation sequencing analyses of the follicular variant of papillary thyroid carcinoma may elucidate the biological underpinnings and clinical behavior of an increasingly common disease, according to data presented at the 82nd ATA Annual Meeting in Québec City, Québec, Canada.
ScienceDaily (Sep. 20, 2012) Exposures to perchlorate (ClO4), a compound found at low levels in the environment, and thiocyanate (SCN), a compound found in cigarette smoke and some foods, is unlikely to alter thyroid function in pregnant women and fetuses, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association (ATA) in Québec City, Québec, Canada. “The developing fetus is reliant on maternal iodine for thyroid hormone production for normal neurodevelopment
Children, young adults treated with radioactive iodine at elevated risk of developing secondary primary cancer
ScienceDaily (Sep. 20, 2012) Children and young adult thyroid cancer patients who are treated with radioactive iodine have an elevated risk of developing a second primary malignancy, according to new data presented at the 82nd Annual Meeting of the American Thyroid Association in Québec City, Québec, Canada. “The expected survival time for young patients with differentiated thyroid cancer is long.
ScienceDaily (June 25, 2012) A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results were presented June 25 at The Endocrine Society’s 94th Annual Meeting in Houston. “Type 2 diabetes increases the risk for several types of cancer,” said lead author Diego Espinoza-Peralta, MD, an endocrinologist with Mexico’s National Institute of Medical Sciences and Nutrition (Instituto Nacional de Ciencias Medicas y Nutricion) in Mexico City
ScienceDaily (June 25, 2012) Hormone-replacement therapy significantly improved symptoms of metabolic syndrome associated with testosterone deficiency in men, a new study from Germany finds. The results will be presented June 25 at The Endocrine Society’s 94th Annual Meeting in Houston.
ScienceDaily (June 23, 2012) Even moderate thyroid dysfunction during early pregnancy significantly increases the risk of serious complications, underscoring the need for universal screening in the first trimester, a new study finds. The results will be presented June 23 at The Endocrine Society’s 94th Annual Meeting in Houston